Correlation Between Vericel Corp and CG Oncology,

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Vericel Corp and CG Oncology, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vericel Corp and CG Oncology, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vericel Corp Ord and CG Oncology, Common, you can compare the effects of market volatilities on Vericel Corp and CG Oncology, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vericel Corp with a short position of CG Oncology,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vericel Corp and CG Oncology,.

Diversification Opportunities for Vericel Corp and CG Oncology,

-0.35
  Correlation Coefficient

Very good diversification

The 3 months correlation between Vericel and CGON is -0.35. Overlapping area represents the amount of risk that can be diversified away by holding Vericel Corp Ord and CG Oncology, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CG Oncology, Common and Vericel Corp is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vericel Corp Ord are associated (or correlated) with CG Oncology,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CG Oncology, Common has no effect on the direction of Vericel Corp i.e., Vericel Corp and CG Oncology, go up and down completely randomly.

Pair Corralation between Vericel Corp and CG Oncology,

Given the investment horizon of 90 days Vericel Corp Ord is expected to generate 0.74 times more return on investment than CG Oncology,. However, Vericel Corp Ord is 1.35 times less risky than CG Oncology,. It trades about 0.07 of its potential returns per unit of risk. CG Oncology, Common is currently generating about 0.01 per unit of risk. If you would invest  2,458  in Vericel Corp Ord on September 3, 2024 and sell it today you would earn a total of  3,356  from holding Vericel Corp Ord or generate 136.53% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy43.64%
ValuesDaily Returns

Vericel Corp Ord  vs.  CG Oncology, Common

 Performance 
       Timeline  
Vericel Corp Ord 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Vericel Corp Ord are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite quite unfluctuating technical and fundamental indicators, Vericel Corp disclosed solid returns over the last few months and may actually be approaching a breakup point.
CG Oncology, Common 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days CG Oncology, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, CG Oncology, is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.

Vericel Corp and CG Oncology, Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Vericel Corp and CG Oncology,

The main advantage of trading using opposite Vericel Corp and CG Oncology, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vericel Corp position performs unexpectedly, CG Oncology, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CG Oncology, will offset losses from the drop in CG Oncology,'s long position.
The idea behind Vericel Corp Ord and CG Oncology, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Other Complementary Tools

Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges